ZA200309656B - Preparation of flumethasone and its 17-carboxyl androsten analogue. - Google Patents

Preparation of flumethasone and its 17-carboxyl androsten analogue.

Info

Publication number
ZA200309656B
ZA200309656B ZA200309656A ZA200309656A ZA200309656B ZA 200309656 B ZA200309656 B ZA 200309656B ZA 200309656 A ZA200309656 A ZA 200309656A ZA 200309656 A ZA200309656 A ZA 200309656A ZA 200309656 B ZA200309656 B ZA 200309656B
Authority
ZA
South Africa
Prior art keywords
flumethasone
acetate
preparation
6alpha
16alpha
Prior art date
Application number
ZA200309656A
Other languages
English (en)
Inventor
Zita Mendes
Ivan Villax
Original Assignee
Hovione Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20086054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200309656(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hovione Ltd filed Critical Hovione Ltd
Publication of ZA200309656B publication Critical patent/ZA200309656B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Control Of Combustion (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
ZA200309656A 2001-06-12 2003-12-12 Preparation of flumethasone and its 17-carboxyl androsten analogue. ZA200309656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102628A PT102628B (pt) 2001-06-12 2001-06-12 Novo processo de preparação de flumetasona e do seu análogo 17-carboxilo androsteno

Publications (1)

Publication Number Publication Date
ZA200309656B true ZA200309656B (en) 2004-06-22

Family

ID=20086054

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200309656A ZA200309656B (en) 2001-06-12 2003-12-12 Preparation of flumethasone and its 17-carboxyl androsten analogue.

Country Status (19)

Country Link
US (1) US6528666B1 (sv)
EP (1) EP1395603B1 (sv)
JP (1) JP4095018B2 (sv)
CN (1) CN1244593C (sv)
AT (1) ATE460422T1 (sv)
AU (1) AU2002310616B2 (sv)
CA (1) CA2450661C (sv)
CY (1) CY1109960T1 (sv)
DE (1) DE60235625D1 (sv)
DK (1) DK1395603T3 (sv)
ES (1) ES2338768T3 (sv)
IL (2) IL159343A0 (sv)
NO (1) NO326153B1 (sv)
NZ (1) NZ530536A (sv)
PL (1) PL206731B1 (sv)
PT (1) PT102628B (sv)
RU (1) RU2260596C1 (sv)
WO (1) WO2002100878A1 (sv)
ZA (1) ZA200309656B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005188A (es) 2001-11-29 2004-08-11 Taro Pharma Ind Metodo para la produccion de 6-alfa-fluorocorticosteroides.
MXPA05006279A (es) * 2002-12-09 2006-01-27 Sicor Inc Proceso para la preparacion de pregnanos.
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
CN100429221C (zh) * 2005-10-31 2008-10-29 浙江仙琚制药股份有限公司 皮质激素的合成方法
CN101759761B (zh) * 2008-11-28 2012-08-08 天津金耀集团有限公司 含有6α-F的甾体化合物的制备方法
EP2386634A4 (en) 2009-01-07 2012-07-18 Mitsubishi Chem Corp ENZYMATIC STEROL LATERAL CHAIN CLEAVAGE PROTEIN AND USE THEREOF
CN101942002A (zh) * 2010-09-24 2011-01-12 岳阳环宇药业有限公司 一种甾体21位酯化物的精制工艺
ITMI20122200A1 (it) * 2012-12-20 2014-06-21 Trifarma Spa Processo per la preparazione di 6-alfa-fluoro pregnani
RU2532902C1 (ru) * 2013-07-12 2014-11-20 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) Способ получения 11бета, 17альфа, 21-тригидрокси-16альфа-метил-9альфа-фторпрегна-1,4-диен-3,20-диона (дексаметазона) из фитостерина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499016A (en) 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
US3636010A (en) 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4188322A (en) * 1978-04-28 1980-02-12 Blasinachim S.P.A. Process for the preparation of 6-halo-pregnanes
FR2701262B1 (fr) 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
IT1319663B1 (it) * 2000-11-17 2003-10-23 Farmabios Srl Processo per la preparazione di fluoro-steroidi.

Also Published As

Publication number Publication date
PL206731B1 (pl) 2010-09-30
PT102628A (pt) 2002-12-31
EP1395603B1 (en) 2010-03-10
CA2450661C (en) 2008-01-08
AU2002310616B2 (en) 2007-08-30
CY1109960T1 (el) 2014-09-10
PT102628B (pt) 2010-09-09
IL159343A0 (en) 2004-06-01
ES2338768T3 (es) 2010-05-12
NO326153B1 (no) 2008-10-06
DE60235625D1 (de) 2010-04-22
PL367843A1 (en) 2005-03-07
RU2260596C1 (ru) 2005-09-20
RU2004100309A (ru) 2005-07-10
CN1244593C (zh) 2006-03-08
JP2004534795A (ja) 2004-11-18
AU2002310616A2 (en) 2002-12-23
WO2002100878A1 (en) 2002-12-19
CA2450661A1 (en) 2002-12-19
EP1395603A1 (en) 2004-03-10
US6528666B1 (en) 2003-03-04
ATE460422T1 (de) 2010-03-15
DK1395603T3 (da) 2010-05-10
CN1531544A (zh) 2004-09-22
NZ530536A (en) 2005-05-27
JP4095018B2 (ja) 2008-06-04
IL159343A (en) 2010-11-30
NO20035517D0 (no) 2003-12-11

Similar Documents

Publication Publication Date Title
CY1109960T1 (el) Παρασκευη φλουμεθαζονης και του αναλογου αυτης17-καρβοξυλο-ανδροστενιου
MY106725A (en) Method of treatment of androgen-related diseases.
NO164905C (no) Fremgangsmaate for fremstilling av 16,17-acetal-pregnanderivater.
AU649472B2 (en) New pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions and method for the treatment of inflammatory conditions
NZ610068A (en) Compositions comprising povidone-iodine
WO2004002404A3 (en) Compositions and method for enhanced mucosal delivery of interferon beta
HK1082682A1 (en) Pharmaceutical composition
HUP9903747A2 (hu) Új eljárás mometazon-furoát előállítására
GR3021436T3 (en) New process for the production of 11-keto steroids
IL164159A0 (en) C-17 spirolactonization and 6,7 oxidation of steroids
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
EP1194109A4 (en) TOPICAL FORMULATIONS CONTAINING AGENTS THAT PROMOTE SKIN PENETRATION AND THEIR USE
MY136880A (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
HRP20031068A2 (en) Chloromethylation of thiophene
AU571073B2 (en) Pharmaceutical composition of 9a, 11b-dichcoro-16a-methl-21-oxycarbonyl dicyclohexycmethycoxy pregna-1,4-diene-3,20-dione
Henley et al. EFFECT OF IONIZING RADIATION ON AQUEOUS ETHYLENE OXYGEN SOLUTIONS
MXPA03011751A (es) Proceso para preparar 21-acetato de 11b,17a, 21-trihidroxi-6a-metilpregna-1, 4-dieno-3, 20- diona.
GB1367928A (en) Halogenopregnadiene and process for its manufacture
IT1302657B1 (it) Processo stereoselettivo per la preparazione di budesonide nella formadi epimero 22-r.
Moriwaki et al. Treatment of Subglottic Stenosis
GB1064078A (en) 5-a-pregnano-[3,2-c]pyrazole compounds
GB979769A (en) 16ª‰-acetyl-3:20-diketosteroids,their manufacture and use
GB978725A (en) Novel steroid compounds and processes for their perparation
IT1247692B (it) 6 fluoro 6 metilpregn-4-ene-3,20 dioni e 6-fluoro-6-metilpregna-l, 4-diene-3,20-dioni,procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' anti-infiammatoria che li contengono
EP0391503A3 (en) Preparation of 7 beta-hydroxy-4-pregnene-3,20-dione derivatives